Brevan Howard Capital Management’s Century Therapeutics IPSC Stock Holding History

Brevan Howard Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$218K	Buy	+96,641	New	+$203K	﹤0.01%	1844

Other funds holding IPSC

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Brevan Howard Capital Management's IPSC Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Century Therapeutics (IPSC) in Q1 2026: 96,641 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1844 among its holdings.

72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Brevan Howard Capital Management held 96,641 shares of Century Therapeutics worth $218K as of Q1 2026.
Century Therapeutics was a new Brevan Howard Capital Management position in Q1 2026.
Century Therapeutics made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1844 holding.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.